Kyntra Bio, Inc. (0IL8.L) LSE

9.45

+0.09(+0.96%)

Updated at January 14 06:01PM

Currency In USD

Valuation

Market Cap1.32B
Enterprise Value1.36B
P/E Ratio0.17
PEG Ratio0
Price/Sales Ratio-0.31
Price/Book Ratio-2.15
Enterprise/Revenue0.52
Enterprise/EBITDA0.48

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.83
Operating Margin1.05

Management Effectiveness

Return On Assets1.57
Return On Equity-1.26

Income Statement

Revenue29.62M
Revenue/Share-29.2
Gross Profit14.06M
EBITDA-142.43M
Net Income-47.58M
Diluted EPS-0.48

Balance Sheet

Total Cash117.98M
Total Cash/Share29.17
Total Debt19.47M
Total Debt/Equity-1.14
Current Ratio3.71
Book Value Per Share4.32

Price History

52-Week Change-35.76
52-Week High20.8
52-Week Low0.34
Moving Average 50 Days1.58
Moving Average 200 Days2.79

Statistics

Average Volume28,076
Shares Outstanding4.04M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateJune 17, 2025